-
If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
<p>According to a law firm a securities class action has been filed against Genelabs Technologies, Inc. (Nasdaq: GNLB), its Board of Directors and GlaxoSmithKline PLC (”Defendants”) on behalf of all securities purchasers of Genelabs Technologies, Inc. over the proposed acquisition of Genelabs Technologies, Inc. by GlaxoSmithKline PLC. The shareholders alleges that the prices is ...
You must register (for free) or login to view the entire case.
